Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties
about
Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismDifferentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.Which CAM modalities are worth considering?Synthesis and characterization of a new Peptide prodrug of glucosamine with enhanced gut permeability.Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage DegradationGlucosamine and chondroitin use in canines for osteoarthritis: A reviewUP1304, a Botanical Composition Containing Two Standardized Extracts of Curcuma longa and Morus alba, Mitigates Pain and Inflammation in Adjuvant-induced Arthritic Rats.A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine.Therapeutic Efficacy of Ozone Injection into the Knee for the Osteoarthritis Patient along with Oral Celecoxib and Glucosamine.Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
P2860
Q21284705-1CDFF1D8-1E1E-4D60-971C-ABBC49C64D79Q30235140-375140ED-653D-4389-9CB6-BA29CAF511BDQ30714596-192C15C7-7A64-49DA-B945-DC8B5EDB30AEQ34423402-2D32F2D3-09DB-4660-89A3-28EDB57637FAQ34854716-183B9E8E-33BB-48E5-A4E6-BCA95D9457A6Q35632646-37283B61-9D90-4DEB-B82E-42604C8AF7C7Q36224923-377F9BD2-5D53-44FA-8D8C-9BF3D3553FACQ37708334-60C80B18-A596-4A2E-BC80-C73F8DBA9B20Q38806168-F9A569F2-AC60-4A5F-9764-6E6EB91BF1CAQ42292745-D539A0A2-46B3-4CCF-BD0B-C17F73525454Q47137980-3592C441-5C2A-4730-8CA0-4DF16F66E753Q47816389-9D1D6FE6-27A3-4CB7-AF8C-48070845A16B
P2860
Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@ast
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@en
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@nl
type
label
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@ast
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@en
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@nl
prefLabel
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@ast
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@en
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@nl
P2860
P3181
P356
P1476
Crystalline glucosamine sulfat ...... and pharmacokinetic properties
@en
P2093
Federica Girolami
Stefano Persiani
P2860
P304
P3181
P356
10.1177/1759720X12437753
P407
P577
2012-06-01T00:00:00Z